Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 486-494

  Montravers, P ^a,b   Gauzit, R ^a   Muller, C ^a   Marmuse, J P ^a   Fichelle, A ^a   Desmonts, J M ^a  

^a Serv de Chir Gen   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL FLORA; BACTERIAL PERITONITIS; BACTERIUM CULTURE; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REOPERATION;

EID: 0029833749     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.486     Document Type: Article

References (16)

1. Bohnen J, Boulanger M, Meakins JL, McLean APH. Prognosis in generalized peritonitis: relation to cause and risk factors. Arch Surg 1983; 118: 285-90.
2. Hinsdale JG, Jaffe BM. Re-operation for intra-abdominal sepsis: indications and results in modern critical care setting. Ann Surg 1984; 199: 31-6.
3. Pitcher WD, Musher DM. Critical importance of early diagnosis and treatment of intra-abdominal infection. Arch Surg 1982; 117:328-33.
4. Mosdell DM, Morris DM, Voltura A, et al. Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214:543-9.
5. McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962; 110:847-55.
6. Polk HC Jr, Lopez-Mayor JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery 1969; 66:97-103.
7. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985; 202:685-93.
9. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
10. Finegold SM. Anaerobes: problems and controversies in bacteriology, infections, and susceptibility testing. Rev Infect Dis 1990; 12(suppl 2): S223-30.
11. Sutter VL, Citron DM, Edelstein MAC, Finegold SM. Wadsworth anaerobic bacteriology manual. 4th ed. Belmont, CA: Star Publishing, 1985.
12. Acar JF, Goldstein FW. Disk susceptibility test. In: Lorian V, ed. Antibiotics in laboratory medicine. 2nd ed. Baltimore: Williams & Wilkins, 1986:27-63.
13. Acar J, Bergogne-Berezin E, Chabbert Y, et al. Statement of the Antibiogram Committee of the French Society for Microbiology. Pathol Biol 1991; 39:737-40.
14. Weinstein RA. Multiply drug-resistant pathogens: epidemiology and control. In: Bennet JV, Brachman PS, eds. Hospital infections. 3rd ed. Boston: Little Brown and Company, 1992:265-88.
15. Carlet J, Goldstein FW, Blériot JP, Bahloul F, Dazza FE. Timentin in the antimicrobial treatment of nosocomial and polymicrobial infections. J Antimicrob Chemother 1986; 17(suppl C):149-59.
16. Solomkin JS, Dellinger EP, Christou NV, Busuttil RW. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intraabdominal infections. Ann Surg 1990; 212:581-91.